Schedule 13G ownership disclosure
VERONA PHARMA PLC
Ordinary shares, nominal value 0.05 euro per share · CUSIP: 925050106
Event date: 2025-06-30
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Perceptive Advisors LLC
Shares: 5,507,591 · Class: 6.4%
- Joseph Edelman
Shares: 5,507,591 · Class: 6.4%
- Perceptive Life Sciences Master Fund, Ltd.
Shares: 5,507,591 · Class: 6.4%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000950170-25-108891
- Form type
- SCHEDULE 13G/A
- Filer
- PERCEPTIVE ADVISORS LLC
- CIK
- CIK 1224962
- Filed
- Aug 14, 2025
- Reporting period
- Jun 30, 2025
- Description
- Schedule 13G beneficial ownership